1-112956232-CG-CGG
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The ENST00000429288.2(SLC16A1):c.-45+606_-45+607insC variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00995 in 153,310 control chromosomes in the GnomAD database, including 26 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.010 ( 26 hom., cov: 31)
Exomes 𝑓: 0.0027 ( 0 hom. )
Consequence
SLC16A1
ENST00000429288.2 intron
ENST00000429288.2 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.424
Genes affected
SLC16A1 (HGNC:10922): (solute carrier family 16 member 1) The protein encoded by this gene is a proton-linked monocarboxylate transporter that catalyzes the movement of many monocarboxylates, such as lactate and pyruvate, across the plasma membrane. Mutations in this gene are associated with erythrocyte lactate transporter defect. Alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 1-112956232-C-CG is Benign according to our data. Variant chr1-112956232-C-CG is described in ClinVar as [Likely_benign]. Clinvar id is 291916.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.01 (1523/152204) while in subpopulation AFR AF= 0.0339 (1410/41538). AF 95% confidence interval is 0.0325. There are 26 homozygotes in gnomad4. There are 715 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 26 SD gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC16A1 | NM_003051.4 | upstream_gene_variant | ENST00000369626.8 | NP_003042.3 | ||||
SLC16A1 | NM_001166496.2 | upstream_gene_variant | NP_001159968.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC16A1 | ENST00000429288.2 | c.-45+606_-45+607insC | intron_variant | 3 | ENSP00000397106 | P1 | ||||
SLC16A1 | ENST00000679803.1 | c.-45+1305_-45+1306insC | intron_variant | ENSP00000505879 | P1 | |||||
SLC16A1 | ENST00000369626.8 | upstream_gene_variant | 1 | NM_003051.4 | ENSP00000358640 | P1 | ||||
SLC16A1 | ENST00000458229.6 | upstream_gene_variant | 2 | ENSP00000416167 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0100 AC: 1522AN: 152088Hom.: 26 Cov.: 31
GnomAD3 genomes
AF:
AC:
1522
AN:
152088
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00271 AC: 3AN: 1106Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 608
GnomAD4 exome
AF:
AC:
3
AN:
1106
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
608
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0100 AC: 1523AN: 152204Hom.: 26 Cov.: 31 AF XY: 0.00961 AC XY: 715AN XY: 74404
GnomAD4 genome
AF:
AC:
1523
AN:
152204
Hom.:
Cov.:
31
AF XY:
AC XY:
715
AN XY:
74404
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
Asia WGS
AF:
AC:
7
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | May 10, 2016 | - - |
Hyperinsulinism, Dominant Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at